Hjem › Metastatisk kreft › California › Mountain View
Kliniske studier for Metastatisk kreft i Mountain View, CA
25 studier for Metastatisk kreft søker deltakere på steder i og rundt Mountain View (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi unna
- VA Palo Alto Health Care System, Palo Alto · 5 mi unna
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RekruttererFase 1/2
- Stanford, Palo Alto · 5 mi unna
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
RekruttererFase 2/3
- Stanford Cancer Center, Palo Alto · 5 mi unna
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · 5 mi unna
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
RekruttererFase 1/2
- Stanford Medicine, Palo Alto · 5 mi unna
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
RekruttererFase 1
- Stanford Cancer Institute, Stanford · 5 mi unna
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruttererFase 1
- Stanford University Medical Center, Stanford · 5 mi unna
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RekruttererFase 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi unna
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruttererFase 3
- Stanford Cancer Center, Palo Alto · 5 mi unna
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- Stanford Cancer Institute, Stanford · 5 mi unna
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
RekruttererFase 2
- Stanford University, Palo Alto · 5 mi unna
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
RekruttererFase 3
- Research Site, Palo Alto · 5 mi unna
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
RekruttererFase 1/2
- Stanford Cancer Institute (SCI), Stanford · 5 mi unna
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RekruttererFase 1
- Stanford Medicine Cancer Center, Stanford · 5 mi unna
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi unna
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
RekruttererFase 3
- Stanford University School of Medicine, Palo Alto · 5 mi unna
A Study of LY4175408 in Participants With Advanced Cancer
RekruttererFase 1
- Stanford Medicine Cancer Center, Stanford · 5 mi unna
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
RekruttererFase 1/2
- Stanford Cancer Institute, Stanford · 5 mi unna
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
RekruttererFase 2/3
- Stanford Health Care - Skin Cancer Program, Stanford · 5 mi unna
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
RekruttererFase 2/3
- Stanford Cancer Institute, Palo Alto · 5 mi unna
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RekruttererFase 1
- Stanford Cancer Institute, Stanford · 5 mi unna
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
RekruttererFase 1
- Stanford Cancer Institute, Stanford · 5 mi unna
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
RekruttererObservasjonsstudie
- VA Palo Alto Healthcare System, Palo Alto · 5 mi unna
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
RekruttererFase 1
- Stanford Cancer Institute, Palo Alto · 5 mi unna
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Stanford · 5 mi unna
Metastatisk kreft-studier i andre byer
- Houston, TX104 studier
- New York City, NY93 studier
- Nashville, TN70 studier
- Boston, MA63 studier
- Los Angeles, CA57 studier
- St. Louis, MO54 studier
- Arlington, VA53 studier
- Philadelphia, PA46 studier
- Chicago, IL45 studier
- San Antonio, TX44 studier
- Washington, DC43 studier
- Dallas, TX42 studier
Andre studier i Mountain View
- Kreft (alle typer)40 studier
- Brystkreft26 studier
- Ikke-småcellet lungekreft21 studier
- Akut myelogen leukemi19 studier
- Eggstokkreft19 studier
- Autismespekterforstyrrelse17 studier
- Lungekreft17 studier
- Prostatakreft15 studier
- Hjertesvikt15 studier
- Autisme13 studier
- Akut lymfoblastisk leukemi13 studier
- Kolorektal kreft13 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.